The cost of insulin could decrease for patients with diabetes after a bill capping copays at $100 a month was advanced by lawmakers in Utah, as reported in The Washington Times.
"It curtails the cost to the public," said Kelly Atkinson, director at the Utah Health Insurance Association, but "the pharmaceutical companies control the cost of insulin."
The state's House Health and Human Services Committee unanimously approved the bill that would place a cap on the amount certain insurance plans can charge for a month's supply of insulin.
The bill will next move to the full House for consideration.
To read more NewsPoints articles, click here.